Diagnostyka SA (DIA.WA) stock: key figures, P/E, revenue and dividend
Health Care · Poland · ISIN PLDGNST00012
Diagnostyka SA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.95 bn PLN | 2.41 bn PLN |
| Gross profit | 1.53 bn PLN | 1.91 bn PLN |
| Operating income | – | 383.66 m PLN |
| EBIT | 324.00 m PLN | – |
| Net income | 223.00 m PLN | 251.60 m PLN |
| Diluted EPS – continuing operations | 6.62 PLN | 7.45 PLN |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Diagnostyka SA
Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers specialized research in the field of microbiology, autoimmunity, toxicology, and molecular biology, as well as human genome research, histopathological examinations, immunohistochemical tests, cytological tests, and cytogenetic tests. The company provides services to individual clients, and public and private entities. Diagnostyka S.A. was founded in 1998 and is headquartered in Kraków, Poland.
More stocks
- Nutex Health Inc. (NUTX)
- Valeura Energy Inc (VLE.TO)
- Forestar Group Inc. (FOR)
- 361 Degrees International Ltd (1361.HK)
- AMAG Austria Metall AG (AMAG.VI)
- Shanghai MicroPort EV MedTech Co. Ltd. A (688351.SS)
- PowerTECH Co. Ltd. A (301369.SZ)
- GKG Precision Machine Co. Ltd. A (301338.SZ)
- Sunvim Group Co Ltd (002083.SZ)
- Vistry Group PLC (VTY.L)
- Vitec Software Group AB (publ) (VIT B.ST)
- Hyundai Department (069960.KS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.